Upstream bioprocessing

Peristaltic pumps and dosing control loops that deliver nutrients into a bioreactor on a fed-batch or perfusion schedule — the subsystem, usually bundled into a broader bioprocess controller rather than sold standalone, that determines whether a culture starves, overfeeds or hits its intended growth curve.

Mass flow controllers and gassing installations that blend oxygen, carbon dioxide, nitrogen and air to precise setpoints and deliver them through a bioreactor's sparger — the subsystem that stabilizes dissolved oxygen and pH and is directly implicated in batch-to-batch yield variability when gas control drifts.

Purpose-built anaerobic bioreactors — tall bubble-column loop vessels, hollow-fiber cell-retention skids, and multi-stage gas cleanup trains — that let acetogenic bacteria convert steel-mill and refinery waste gas (CO, CO2, H2) into ethanol at commercial scale, one plant already running at 210,000 tonnes/year of biofuel-grade output.

Bioreactor hardware engineered to sustain far higher viable-cell densities than a conventional stirred tank — Repligen's XCell ATF perfusion system (100M+ cells/mL), PBS Biotech's Vertical-Wheel bioreactors, Univercells Technologies' scale-X fixed-bed platform, and Cellexus's CellMaker airlift bioreactors — the equipment layer that lets a fed-batch or perfusion process pack more cells and more product into the same reactor volume.

Automated mini- and micro-bioreactors (1-250 mL) running 24-48 cultures in parallel that map a bioprocess Design Space in days rather than months — the high-throughput on-ramp to cell-line, strain and upstream-process development, led by the German ambr, BioLector and DASbox platforms.

Gamma-irradiated single-use bag bioreactors in the 50-2000 L stirred-tank class — Sartorius Biostat STR, Cytiva Xcellerex XDR, Thermo Fisher HyPerforma, Merck Mobius — that replaced stainless steel for clinical and commercial mAb, vaccine and cell-and-gene-therapy manufacturing, cutting facility build-out from years to weeks and underpinning the CDMO economy.

Disposable bioreactors, bags and tubing plus modular factories (KUBio — 12–18 months vs 5–7 years) cut capex and cross-contamination, making biomanufacturing flexible and multi-product.

Solid-state fermentation (SSF) bioreactors cultivate filamentous fungi, yeasts and bacteria on moist solid substrates — wheat bran, soybeans, rice, bagasse — at 40–70% moisture without free liquid, producing industrial enzymes (Aspergillus phytase, xylanase), organic acids, koji for shoyu/miso/sake, and biocontrol conidia (Beauveria, Trichoderma) at 3–5× lower cost than submerged fermentation, engineered around tray, rotating-drum and forced-aeration packed-bed hardware that solve SSF's defining challenges of heat removal, moisture control and oxygen transfer in a low-water matrix.

Single-use wave and rocking-bag bioreactors — Cytiva WAVE/Xuri, Sartorius Biostat RM, Thermo Fisher HyPerforma Rocker and Applitech AbioWave — that expand CHO, HEK293, stem-cell and cell-therapy seed trains under low-shear wave mixing without stirred impellers or clean-in-place.